治療用レーザーの世界市場予測（2022年～2027年）

世界の治療用レーザーの市場規模は、2020年に1,036億6,400万米ドルとなりました。

当レポートでは、世界の治療用レーザー市場について調査し、市場規模や予測、COVID-19の影響、市場の促進要因および課題、市場動向、セグメント別の市場分析、競合情勢、主要企業のプロファイルなどの体系的な情報を提供しています。

目次

第1章 イントロダクション

• 市場概要
• COVID-19の影響
• 市場の定義
• 市場セグメンテーション

第2章 調査手法

• 調査データ
• 前提条件

第3章 エグゼクティブサマリー

• 調査のハイライト

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• 業界のバリューチェーン分析

第5章 世界の治療用レーザー市場：治療別

• イントロダクション
• 炭酸ガスレーザー
• YAG（イットリウムアルミニウムガーネット）レーザー
• パルス色素レーザー
• アルゴンレーザー
• 低レベルレーザー治療（LLLT）

第6章 世界の治療用レーザー市場：用途別

• イントロダクション
• レーシック・レーザー眼科手術
• 歯のホワイトニング
• 化粧品の傷跡、タトゥー、しわの除去
• 腫瘍の除去
• その他

第7章 世界の治療用レーザー市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • スペイン
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • その他
• アジア太平洋地域
  • 中国
  • 日本
  • 韓国
  • インド
  • タイ
  • その他

第8章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場の有利性
• 合併、買収、契約、コラボレーション
• ベンダーの競合マトリックス

第9章 企業プロファイル

• BTL
• ERCHONIA CORPORATION
• Theralase (R) Technologies Inc.
• Cutting Edge Laser Technologies
• BioFlex Laser Therapy
• El.En. Group
• Lynton Lasers Ltd.
• Fotona d.o.o.
• Capillus, LLC
• LiteCure, LLC

The global therapeutic laser market was valued at US$103.664 billion in 2020.

A therapeutic laser system is a drug-free, non-invasive therapy approach that relieves chronic and acute pain while also improving blood circulation. These devices employ LASER laser pulses that penetrate through the skin without creating warmth, injury, or other negative effects. The therapeutic laser system speeds up wound healing and lowers soft tissue inflammation and discomfort. Therapeutic laser therapy is viewed as an alternative, if not a supplement, to standard medication and surgical treatment. Therapeutic laser systems include a long-term therapeutic effect by addressing the fundamental causes of illness disorders.

Increased cancer incidences

The need for a therapeutic laser is increasing due to rising cancer occurrences globally, an increase in the number of operations, and increased awareness of self-care and self-management. Furthermore, increased disposable income, rising healthcare spending, and shorter hospital stays would drive the worldwide therapeutic laser market in the projected decade and beyond. Furthermore, increased disposable income, rising healthcare spending, and shorter hospital stays would drive the worldwide therapeutic laser market in the projected decade and beyond. Moreover, several companies have taken the initiative to launch new innovative products that have propelled the market to grow during the projected period. For instance, Theralase Technology, a Canadian producer of patent laser technologies in both the Anti-Cancer Therapy (ACT) and Medical Laser Technology (MLT) sectors, intends to introduce new, breakthrough pain and cancer solutions in 2021. They've also shown that their primary PDC can eliminate several viruses, including H1N1 flu and Zika.

North America has been a major market for therapeutic lasers until now and is expected to witness a surge in its global market share.

This can be attributed to the growing prevalence of demand for cosmetic surgeries across several countries in this region. Primary cosmetic treatments for veins, skin resurfacing, and hair removal using laser therapy have increased significantly in the region. For instance, according to the American Society of Plastic Surgeons annual report, it was reported that 168,682 laser treatments for veins, 997,245 laser skin resurfacing, and 757,808 laser removal procedures were performed in 2020. Thus, these extensive medical applications and the wide adoption of these procedures have propelled the demand for the therapeutic lasers market in the region. Further, the growing demand for these lasers can also be attributed to an increase in the provision of patents in the region. For instance, in July 2021, Aspen Laser LLC, which is a major medical solutions company, was awarded a new patent by the USPTO (U.S. Patent and Trademark Office). The patent was reported to cover particular laser devices that would be manufactured by the company and sold in the veterinary and medical markets.

Furthermore, major companies in the region have been focused on the implementation of strategic initiatives such as mergers, collaborative agreements, and acquisitions, for the consolidation of their position in the market. For instance, in September 2021, Boston Scientific completed the acquisition of the worldwide surgical business of Lumenis LTD, an energy-based medical solutions company, from an affiliate of BPEA (Baring Private Equity Asia). The surgical business of Lumenis comprised of fibers, premier laser systems, and accessories that are deployed in the otolaryngology and urology procedures. Thus, developments like these are further expected to propel growth in the market.

Market Key Developments

• In July 2022, The Palm Beach County Golf Association established an official partnership with LUMACARE DUO, a premier supplier of cold laser treatment for acute and chronic pain. To fulfill their clients' growing demands, they created a new type of Cold Laser system, one that is meant to enhance treatment efficacy and improve patient results.
• In October 2020, Summus Medical Laser, the leading manufacturer of high-powered laser treatment devices, announces the release of the Horizon Medical Laser System, the first Class IV therapy laser system particularly developed for the medical profession. The Horizon Medical Laser System is the inaugural Class IV diode laser created specifically for the medical sector. The system brings a unique capacity combining four separate frequencies that can be regulated individually, offering the most sophisticated laser treatment option on the market, with 28 watts of power. With condition-specific protocols, its dynamic mix of power, wavelength, and pulse offers an appropriate therapeutic laser dosage in less time.
• In July 2019, NIDEK CO., LTD., a global pioneer in the design, production, and distribution of ophthalmic, eye care, and lens edging equipment, announced the release of LPM optional technology, a low wattage mode for the YLC-500 Vixi laser photocoagulator. By lowering the laser strength during photocoagulation, LPM provides a therapeutic impact on the retina. The typical laser strength is reduced by a predetermined ratio during therapy, resulting in less invasive photocoagulation of the macular area.

Segmentation

• By Therapy

Carbon Dioxide Laser

YAG (yttrium aluminum garnet) Laser

Pulsed Dye Laser

Argon Laser

Low level laser therapy (LLLT)

• By Application

LASIK or Laser Eye Surgery

Teeth Whitening

Cosmetic Scar, Tattoo or Wrinkle Removal

Tumor Removal

Others

• By Geography

North America

• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others

Europe

• Germany
• France
• United Kingdom
• Spain
• Others

Middle East and Africa

• Saudi Arabia
• UAE
• Others

Asia Pacific

• China
• Japan
• South Korea
• India
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. COVID-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. GLOBAL THERAPEUTIC LASER MARKET, BY THERAPY

• 5.1. Introduction
• 5.2. Carbon Dioxide Laser
• 5.3. YAG (yttrium aluminum garnet) Laser
• 5.4. Pulsed Dye Laser
• 5.5. Argon Laser
• 5.6. Low level laser therapy (LLLT)

6. GLOBAL THERAPEUTIC LASER MARKET, BY APPLICATION

• 6.1. Introduction
• 6.2. LASIK or Laser Eye Surgery
• 6.3. Teeth Whitening
• 6.4. Cosmetic Scar, Tattoo or Wrinkle Removal
• 6.5. Tumor Removal
• 6.6. Others

7. GLOBAL THERAPEUTIC LASER MARKET, BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. Japan
  • 7.6.3. South Korea
  • 7.6.4. India
  • 7.6.5. Thailand
  • 7.6.6. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

• 9.1. BTL
• 9.2. ERCHONIA CORPORATION
• 9.3. Theralase® Technologies Inc.
• 9.4. Cutting Edge Laser Technologies
• 9.5. BioFlex Laser Therapy
• 9.6. El.En. Group
• 9.7. Lynton Lasers Ltd.
• 9.8. Fotona d.o.o.
• 9.9. Capillus, LLC
• 9.10. LiteCure, LLC